Physician profile
Vivek Venugopal
NPI 1992183917
$17,797.63
in general payments reported to CMS, 2019-2025
7 companies · $3,916 in 2025
The $3,916 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,360 · 2023: $6,312 · 2024: $3,210 · 2025: $3,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,563 · Education: $3,188 · Travel and Lodging: $2,851 · Food and Beverage: $2,337 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,562.50 |
| Education | $3,187.50 |
| Travel and Lodging | $2,850.56 |
| Food and Beverage | $2,337.16 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,373.33 | 2022-2025 | Journey II, Or3o Dual Mobility, Journey |
| Medical Device Business Services, INC. | $3,760.49 | 2024-2025 | Velys |
| Stryker Corporation | $2,732.06 | 2022-2025 | Mako, Triathlon, Exeter |
| Encore Medical, LP | $1,500.00 | 2023 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $255.47 | 2023 | Affixus, Persona |
| Wishbone Medical INC. | $150.07 | 2023 | |
| Trimed, INC. | $26.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Venugopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.